Media Coverage | Vossel Research Lab

2024

May 21, 2024: Interviewed by Daily Mail for article, “' Can some people REALLY remember their own birth? Experts give their verdict after Terrence Howard made astonishing claim on Joe Rogan's podcast.”
April 18, 2024 : Interviewed by Daily Mail for article, “' Dr Oz accused of using his mother's dementia diagnosis to promote his 'bogus' supplements.”
March 23, 2024: Interviewed by Axios Science for article, “Middle age's hidden perils — and possibilities — for the aging brain.”
March 20, 2024: Interviewed by USA Today for article, “6.9 million Americans have Alzheimer's disease: How to reduce your risk.”
January 31, 2024: Interviewed by Fierce Biotech for article, “Beyond sensational headlines of transmitted Alzheimer's, scientists see stronger case for prion theory.”
January 17, 2024: Interviewed by Daily Mail for article, “'Worn out' Trump, 77, sparks health fears despite resounding Iowa win as he fights to stay out of prison, save his business and win the White House.”

2023

November 21, 2023: Vossel lab and MUSIC (Music Stimulation to Improve Cognition) study covered by Marla Tellez in segment on FOX 11 Los Angeles
November 2, 2023: Interviewed by Daily Mail for article, “' How drinking more than eight glasses of water in under an hour can cause SEIZURES- as Brooke Shields reveals over-hydrating caused her to 'foam from the mouth' during fit.”
October 10, 2023: Live interview in studio with Dr. Marc Siegal, Doctor Radio/Channel 110 on Sirius XM Radio. Broadcast from NYU Langone Medical Center. An in depth interview on various neurodegenerative diseases.
August 31, 2023: Interviewed by Daily Mail for article, “'Are mini seizures behind Mitch McConnell’s frightening freeze episodes?”
August 16, 2023: Interviewed by KFF Health News for article, “New Alzheimer’s Drug Raises Hopes — Along With Questions.”
July 26, 2023: Dr. Keith Vossel was interviewed for a Forbes Health article about sundowning and the symptoms that patients with Alzheimer’s disease and dementia may experience. Read the article: Sundowning Occurs in Patients with Alzheimer's and Dementia
July 17, 2023: Dr. Keith Vossel was quoted in a Healthline article about an observational study that revealed maintaining a socially and mentally active lifestyle in late life reduces the risk of dementia. Read the article: Late Life with Active Lifestyle Lowers the Risk of Dementia
July 12, 2023: Dr. Keith Vossel, neurologist and Director of the Easton Center, was quoted in a Boston Globe’s STAT News article regarding physicians and patients showing interest in learning more about the new Alzheimer’s treatment, Leqembi. Read the article: New Released Information About the Additional Medicare Coverages for Leqembi
July 12, 2023:Watch Dr. Keith Vossel's live interview on July 7th, with KCAL-LA Morning News, about the benefits of the treatment, possible side effects, and expected out-of-pocket costs with CMS coverage for patients eligible for Leqembi, a fully FDA-approved Alzheimer’s drug. View the video: Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 2 of 2)
July 11, 2023: Watch Dr. Keith Vossel's live interview with Marla Tellez on July 7th, FOX 11 News LA, about the FDA’s full approval of Alzheimer’s drug, Lecanemab, who is eligible, the treatment benefits, side effects, and expected costs with Medicare coverage. View the video: Lecanemab, the New FDA-approved Alzheimer's Drug - What to Know
July 7, 2023: Dr. Keith Vossel, Neurologist and Director of the Easton Center, was quoted in a San Francisco Chronicle July 7th article about more observations and real-world data needed to determine the effectiveness of the newly approved Alzheimer’s drug, Leqembi. Read the article: Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug
July 6, 2023: Watch Dr. Keith Vossel’s exclusive live interview with KNBC-LA, NBC Channel 4 News, about the FDA’s full approval of the Alzheimer’s drug, Lecanemab, marketed as Leqembi, and what it means for families with loved ones in the early stages of Alzheimer’s disease. View the video: What Families Can Expect with the New FDA-Approved Alzheimer’s Medication, Leqembi
July 12, 2023: View the video: Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 1 of 2)
July 6, 2023: Listen to Dr. Keith Vossel’s exclusive interview with KNX News Radio, aired on July 6, 2023, about the FDA’s full approval of the first-in-class Alzheimer’s drug, Lecanemab, for people with early stages of Alzheimer’s disease; studies showed it to slow progression in cognitive decline. Listen to the audio: What’s Next for Leqembi After A Full Approval by the FDA
June 23, 2023: Dr. Keith Vossel, Director of the Easton Center, was interviewed by Medical News Today and commented on recent Alzheimer’s model research that suggested long-term excessive intake of alcohol can accelerate cognitive decline. Read the article: Heavy Alcohol Intake May Worsen Cognitive Decline in Alzheimer’s Disease
June 7, 2023: Dr. Keith Vossel, Director of the Easton Center, was interviewed by Medical News Today about his viewpoint on a recent paper, which suggested that early detection of abnormal astrocytes could potentially predict the development of Alzheimer’s. Read the article: Recent Paper Suggests That a New Blood Biomarker of Abnormal Astrocytes May Help Predict Alzheimer's
May 22, 2023: Dr. Keith Vossel, Neurologist and Director of the Easton Center, was interviewed by DailyMail about some of the behaviors and emotional changes that patients and caregivers face with frontotemporal dementia, typically before the age of 60. Read the article: Genetic Testing for Frontotemporal Dementia
May 5, 2023: MarketWatch interviewed Dr. Keith Vossel about the results of the Phase 3 trial of Alzheimer's drug, donanemab. Read the article: Good results from Alzheimer's drug trial seen as 'potentially very important'
Apr 20, 2023: Dr. Keith Vossel, Neurologist and Director of the Mary S. Easton Center for Alzheimer’s Research and Care at UCLA, was interviewed by Healthline on April 20, 2023, warning study participants to take precautions when considering a catheter ablation procedure to reduce the risk of developing dementia. Read the article: New study suggests that a catheter ablation for Afib could reduce risk of cognitive decline
February 21, 2023: Gilbert Cordova with ABC10 interviewed Dr. Keith Vossel about the uniqueness of Alzheimer’s new medication, lecanemab, which received accelerated approval by the FDA in early January 2023. Read the article and view the video: What is Unique About the New Alzheimer's Medication?
February 17, 2023: Daily Mail interviewed Dr. Keith Vossel for input on Bruce Willis’ FTD diagnosis and the potential impact on language, personality, and movement. Dr. Vossel discussed clinical studies looking into FTD. Read the article: Dr. Vossel's Gives His Input on Bruce Willis' FTD Diagnosis
January 6, 2023: Dr. Keith Vossel shares his thoughts on the FDA's accelerated approval of lecanemab with the Daily Mail. Read the article: New Alzheimer's Drug Given Accelerated Approval

2022

December 1, 2022: Dr. Keith Vossel was interviewed by Healthline about axonal spheroids in Alzheimer’s disease and a new urine test for Alzheimer’s that can improve diagnostic certainty. Read the article: Axonal Swelling in Alzheimer’s Disease and New Tests May Improve the Certainty of Alzheimer’s Diagnosis
November 29, 2022: Financial Times interviewed Dr. Keith Vossel about his perceptions of treating Alzheimer’s patients with lecanemab. Read the article: Eisai’s Approach To the New Alzheimer’s Drug
November 30, 2022: Dr. Keith Vossel discussed the risks and benefits of lecanemab on CBC News. View the video: Can the New Alzheimer’s Drug Slow the Progression of the Disease?
November 30, 2022: Dr. Keith Vossel’s interview with Jane King from Nasdaq was featured on WISHTV.com, Wednesday’s Business Headlines, about who may benefit from the lecanemab clinical trial study. View the video: The Risk and Benefits of the New Alzheimer’s Drug
July 13, 2022: Dr. Vossel Discussed the Work of the Easton Center on "Radio Night Live" AM970 in NY
Listen to Dr. Keith Vossel's interview with Kevin McCullough, New York's "Radio Night Live" AM970, on July 13, 2022, discussing the causes and risk factors of Alzheimer's disease and the work of the Easton Center in conducting clinical trials and research to find treatments.
June 28, 2022: Alzheimer's and Brain Awareness Month
Dr. Keith Vossel's exclusive interview with Alex Cohen about Alzheimer’s and Brain Awareness Month aired on Tues, June 28, 2022, around 8:40 PM, Spectrum News 1 SoCal Inside the Issues.
March 31, 2022: Dr. Vossel's Op-Ed appeared the L.A. Times. Read the Op-Ed: Did aphasia influence Bruce Willis’ career decisions? Every case is unique
March 15, 2022: Dr. Vossel was interviewed in USA Today. Read the article: Report: Up to 18% of adults over 60 have early stages of memory loss, cognitive problems
February 19, 2022: Dr. Vossel's Op-Ed appeared in the L.A. Times. Read the Op-Ed: The first treatment for Alzheimer's taught us some hard lessons

2021

September 27, 2021: Phase 2a clinical trial published in JAMA Neurology
Low doses of an inexpensive and widely available antiseizure drug improves learning and memory and executive function in AD patients with epileptic activity.
- Read the JAMA Neurology article
- Read the UCLA Health new article